10.14.25 -- Discovery On Hold: How Shutdowns Stall Science And Shake Trust

Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

Standardizing flow cytometry assays on legacy cytometers is challenging. Gain insight on how a global pharmaceutical company successfully transferred cell therapy assays across international locations.

Leveraging computer-aided synthesis design technology and route scouting in the early stages of development can aid you in designing an efficient and cost-effective path to API manufacturing.

Explore how lipid nanoparticles are revolutionizing cell therapy workflows to enable the precise delivery of mRNA and gene editing tools for next-generation treatments like CAR T and HSC therapies.

See how investing early in the right controls not only minimizes risks but also accelerates timelines, streamlines regulatory interactions, and builds trust across the ecosystem.

Understanding the available dermal study options, along with their pros and cons, helps streamline development, reduce costs, and speed regulatory approval.

Take a closer look into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.

If you don’t know where you are going, how will you get there? Articulating the destination of your therapeutic is essential for determining whether it is commercially viable and meets required milestones.